RxSight (RXST) Operating Income (2020 - 2026)
RxSight's (RXST) quarterly Operating Income came in at -$17.8 million in Q1 2026, down 67.03% YoY from -$54.1 million in Q1 2025, and down 57.78% on a QoQ basis from -$11.3 million in Q4 2025.
RxSight (RXST) Operating Income (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Operating Income data on file, last reported at -$17.8 million in Q1 2026.
- Quarterly Operating Income fell 67.03% year-over-year to -$17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55.3 million (down 50.07% YoY) and the FY2025 annual result came in at -$48.2 million, down 30.62% from the prior year.
- Operating Income fell to -$17.8 million in Q1 2026, from -$11.3 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $16.0 million in Q3 2022 to a low of -$89.3 million in Q4 2023.
- A 5-year average of -$10.5 million and a median of -$10.7 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income surged 213.86% — and 2023, when it slumped 495.73%.
- Tracing RXST's Operating Income over 5 years: stood at -$15.0 million in 2022, then tumbled by 495.73% to -$89.3 million in 2023, then jumped by 90.29% to -$8.7 million in 2024, then tumbled by 30.33% to -$11.3 million in 2025, then slumped by 57.78% to -$17.8 million in 2026.
- The last three Operating Income figures came in at -$17.8 million (Q1 2026), -$11.3 million (Q4 2025), and -$12.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 285.80 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | -13.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.80 Mn |
| Mar 31, 2026 | -17.83 Mn |
| Dec 31, 2025 | -11.30 Mn |
| Sep 30, 2025 | -12.20 Mn |
| Jun 30, 2025 | -14.00 Mn |
| Mar 31, 2025 | -10.67 Mn |
| Dec 31, 2024 | -8.67 Mn |
| Sep 30, 2024 | -9.23 Mn |
| Jun 30, 2024 | -8.30 Mn |
| Mar 31, 2024 | -10.67 Mn |
| Dec 31, 2023 | -89.30 Mn |
| Sep 30, 2023 | -12.51 Mn |
| Jun 30, 2023 | 13.60 Mn |
| Mar 31, 2023 | 13.10 Mn |
| Dec 31, 2022 | -14.99 Mn |
| Sep 30, 2022 | 16.00 Mn |
| Jun 30, 2022 | 15.80 Mn |
| Mar 31, 2022 | -16.58 Mn |
| Dec 31, 2021 | 90.92 Mn |
| Sep 30, 2021 | 13.10 Mn |